share_log
Reuters ·  Feb 25 13:00
Evaxion Biotech A/S: Trial Has Been Extended by an Additional Year to Collect Three-Year Clinical Outcome Data
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
Comment Comment · Views 225

Recommended

Write a comment